Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Lutetium Lu 177 Dotatate clinical trials
11 selected ClinicalTrials.gov records carrying the official matched intervention Lutetium Lu 177 Dotatate (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
11 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 10 selected PubMed records and 3 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT04082520
PeptideScanner retained ClinicalTrials.gov record NCT04082520 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- October 13, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT04234568
PeptideScanner retained ClinicalTrials.gov record NCT04234568 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- November 13, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT04529044
PeptideScanner retained ClinicalTrials.gov record NCT04529044 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-06-05, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- June 5, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Lutetium Lu 177 dotatate · 2026-11-13
ClinicalTrials.gov record NCT04234568
Active, not recruiting at the retained observation.
Open attributed record →Lutetium Lu 177 dotatate · 2026-11-12
ClinicalTrials.gov record NCT04665739
Recruiting at the retained observation.
Open attributed record →Lutetium Lu 177 dotatate · 2026-11-12
ClinicalTrials.gov record NCT04750954
Active, not recruiting at the retained observation.
Open attributed record →Lutetium Lu 177 dotatate · 2026-11-12
ClinicalTrials.gov record NCT05691465
Recruiting at the retained observation.
Open attributed record →Lutetium Lu 177 dotatate · 2026-11-12
ClinicalTrials.gov record NCT05773274
Recruiting at the retained observation.
Open attributed record →Lutetium Lu 177 dotatate · 2026-11-02
ClinicalTrials.gov record NCT07910760
Not yet recruiting at the retained observation.
Open attributed record →Lutetium Lu 177 dotatate · 2026-10-20
ClinicalTrials.gov record NCT05247905
Active, not recruiting at the retained observation.
Open attributed record →Lutetium Lu 177 dotatate · 2026-10-13
ClinicalTrials.gov record NCT04082520
Recruiting at the retained observation.
Open attributed record →Lutetium Lu 177 dotatate · 2026-07-31
ClinicalTrials.gov record NCT05724108
Active, not recruiting at the retained observation.
Open attributed record →Lutetium Lu 177 dotatate · 2026-06-24
ClinicalTrials.gov record NCT06016855
Recruiting at the retained observation.
Open attributed record →Lutetium Lu 177 dotatate · 2026-06-05
ClinicalTrials.gov record NCT04529044
Recruiting at the retained observation.
Open attributed record →